← Back to headlines
Drug Recall: Rowatinex Pulled from Market Due to Quality Issues
The State Institute for Drug Control has ordered the immediate withdrawal of two batches of the drug Rowatinex, used for treating urinary and kidney stones, from the market due to quality deficiencies identified during control checks.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
